Head and Neck Cancer Stem Cells: The Effect of HPV—An In Vitro and Mouse Study
Year: 2013
Type: article
Abstract: OBJECTIVES: To determine if the behavior of cancer stem cells (CSCs) is affected by human papillomavirus (HPV) status. STUDY DESIGN: An in vitro and in vivo analysis of HPV and CSCs. SETTING: University laboratory. SUBJECTS AND METHODS: We isolated CSCs from HPV-positive and HPV-negative cell lines. Two HPV-negative cell lines underwent lentiviral transduction of E6/E7. Chemoresistence was determined using colony formation assays. Native HPV-positive and HPV E6/E7-transduced cells were compared for lung colonization after tail vein injection in NOD/SCID mice. RESULTS: The proportion of CSC is not significantly different in HPV-positive or HPV-negative head and neck squamous cell carcinoma (HNSCC) cell lines. The HNSCC CSCs are more resistant to cisplatin than the non-CSCs, but there were no significant differences between HPV-positive and HPV-negative cells. The HPV-negative cancer cells yielded low colony formation after cell sorting. After transduction with HPV E6/E7, increased colony formation was observed in both CSCs and non-CSCs. Results from tail vein injections yielded no differences in development of lung colonies between HPV E6/E7-transduced cells and nontransduced cells. CONCLUSIONS: Human papillomavirus status does not correlate with the proportion of CSCs present in HNSCC. The HPV-positive cells and those transduced with HPV E6/E7 have a greater clonogenicity than HPV-negative cells. The HNSCC CSCs are more resistant to cisplatin than non-CSCs. This suggests that common chemotherapeutic agents may shrink tumor bulk by eliminating non-CSCs, whereas CSCs have mechanisms that facilitate evasion of cell death. Human papillomavirus status does not affect CSC response to cisplatin therapy, suggesting that other factors explain the better outcomes for patients with HPV-positive cancer.
Source: Otolaryngology
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: American Academy of Otolaryngology-Head and Neck Surgery, University of Michigan, China Scholarship Council, University of Michigan Comprehensive Cancer Center, National Cancer Institute, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research
Awards: G1198238485, G1457163447, G248408221, The Molecular Basis of Head and Neck Cancer Biology, Treatment and Prevention, Advanced Research Training in Otolaryngology, Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer, G646528168, Hearing, Balance and Chemical Senses Research Core Center, University of Michigan Rogel Cancer Center Support Grant 2023-2028
OpenAlex ID: W2010764484
